This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Universität Autonoma De Barcelona, Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio), Fundación Del Sector Público Estatal Centro Nacional Dl'investigaciones Oncológicas Carlos III (f.s.p. Cnio). Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 49 
1 out of 4 
1 out of 1 
Years Active: 2019-2022
Title: Ivan Formentini: Innovator in Telomerase Therapies
Introduction
Ivan Formentini is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of therapies related to telomerase reverse transcriptase. With a total of 3 patents, his work focuses on addressing critical health issues associated with telomere length and myocardial infarction.
Latest Patents
Formentini's latest patents include innovative therapies that utilize telomerase reverse transcriptase. One of his inventions provides compositions and methods useful for the treatment and prevention of conditions associated with short telomere length. Another significant patent addresses therapies for the treatment of conditions related to myocardial infarction, offering new hope for patients suffering from this serious health condition.
Career Highlights
Throughout his career, Ivan Formentini has worked with esteemed institutions such as the National Center for Oncological Research Carlos III and the Autonomous University of Barcelona. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Maria Bobadilla and Maria Antonia Blasco Marhuenda. Their collaborative efforts have further advanced the research and development of telomerase-based therapies.
Conclusion
Ivan Formentini's innovative work in telomerase reverse transcriptase therapies highlights his commitment to improving health outcomes. His contributions to biotechnology continue to pave the way for new treatments and advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile